Protein crosslinking as a therapeutic strategy for SOD1-related ALS
Hossain, M. A.; Sarin, R.; Donnelly, D. P.; Miller, B. C.; Salisbury, J. P.; Conway, J. B.; Watson, S.; Winters, J. N.; Alam, N.; Sivasankar, D.; Ponmudiyan, A. C.; Gawde, T.; Kannapadi, S.; Auclair, J. R.; Makowski, L.; Ringe, D.; Ondrechen, M. J.; Chen, Y.; Manetsch, R.; Agar, J. N.
Show abstract
Mutations in the gene encoding Cu-Zn superoxide dismutase 1 (SOD1) cause a subset of familial amyotrophic lateral sclerosis (fALS). One effect of these mutations is that SOD1, which is normally a stable dimer, dissociates into toxic monomers. Considerable research efforts have been devoted to developing compounds that stabilize the dimer of fALS SOD1 variants, but these have not yet resulted in an approved drug. We demonstrate that a cyclic thiosulfinate cross-linker can stabilize prevalent disease-causing SOD1 variants. The degree of stabilization afforded by cyclic thiosulfinates (up to 24 {degrees}C) is unprecedented. We show this compound works rapidly in vivo with a half-life of ~3 days. The efficacy, low toxicity, and pharmacodynamics of cross-linker mediated stabilization make it a promising therapeutic approach for SOD1-related fALS. Significance statementCyclic thiosulfinate S-XL6 enables the kinetic stabilization of ALS-associated SOD1 variants, in vivo.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Granulins modulate liquid-liquid phase separation and aggregation of TDP-43 C-terminal domain 94%
- Targeting the Protein-Protein Interaction Between the CDC37 Co-Chaperone and Client Kinases by an Allosteric RAF Dimer Breaker 94%
- Amyloid-β oligomers are captured by the DNAJB6 chaperone: Direct detection of interactions that can prevent primary nucleation 94%
Similar papers in this journal
- Total Chemical Synthesis of Glycosylated TREM2 Ectodomain 93%
- The double-layered structure of amyloid-β assemblage on GM1-containing membranes catalytically promotes fibrillization 93%
- Exifone is a Potent HDAC1 Activator with Neuroprotective Activity in Human Neuronal Models of Neurodegeneration 92%
Similar papers in this journal
Similar papers in this journal
- Biochemical and structural insights into SARS-CoV-2 polyprotein processing by Mpro 93%
- Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in non-human primates 93%
- VMAT2 dysfunction impairs vesicular dopamine uptake, driving its oxidation and α-synuclein pathology in DJ-1-linked Parkinson's disease neurons 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.